Givaudan reported 2.32B in Current Liabilities for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Akzo Nobel AKZA:NA € 5470M 601M
Arkema AKE:FP € 2620M 627M
Associated British Foods ABF:LN 3.3B 23M
BASF BAS:GR € 25093M 5012M
Bayer BAYN:GR € 31019M 1616M
British American Tobacco BATS:LN 15.14B 3.27B
Covestro 1COV:GR 3.79B 188M
Croda International CRDA:LN 459.9M 40.7M
Diageo DGE:LN 7.6B 462M
Fresenius FRE:GR € 14138M 924M
Fresenius Medical Care FME:GR € 6377.45M 880.18M
Givaudan GIVN:VX 2.32B 96M
Glanbia GLB:ID 887.4M 186.1M
International Flavors Fragrances IFF:US $ 4032M 399M
Johnson Matthey JMAT:LN 3.15B 425M
Kerry Group KYG:ID 2B 76.7M
Lonza Group LONN:SW 2.37B 739M
Merck MRK:GR € 10207M 225M
Solvay SOLB:BB € 6580M 1049M
Tate & Lyle TATE:LN 780M 26M
Umicore UMI:BB 3.48B 524.03M